Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets EXMKT - Delayed Quote USD

Black Bird Biotech, Inc. (BBBT)

Compare
0.0001
0.0000
(0.00%)
At close: April 3 at 4:00:00 PM EDT
Loading Chart for BBBT
  • Previous Close 0.0000
  • Open 0.0001
  • Bid 0.0001 x --
  • Ask 0.0001 x --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0000 - 0.0002
  • Volume 2,000,000
  • Avg. Volume 0
  • Market Cap (intraday) 178,543
  • Beta (5Y Monthly) 2.51
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Black Bird Biotech Inc. provides various biotech products. It manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites. The company also manufactures and sells CBD Oils, gummies and pet treats, CBD-infused personal care products, and hand sanitizer under the Grizzly Creek Naturals brand name. In addition, it grows industrial hemp under the Montana Hemp pilot program. The company was formerly known as Digital Development Partners, Inc. and changed its name to Black Bird Biotech, Inc. in June 2021. Black Bird Biotech, Inc. is based in Argyle, Texas.

www.blackbirdbiotech.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BBBT

View More

Performance Overview: BBBT

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BBBT
0.00%
S&P 500 (^GSPC)
8.25%

1-Year Return

BBBT
0.00%
S&P 500 (^GSPC)
3.55%

3-Year Return

BBBT
99.33%
S&P 500 (^GSPC)
18.71%

5-Year Return

BBBT
99.78%
S&P 500 (^GSPC)
116.85%

Compare To: BBBT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BBBT

View More

Valuation Measures

Annual
As of 10/15/2024
  • Market Cap

    178.54k

  • Enterprise Value

    920.96k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.83

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    25.35

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -147.15%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    36.32k

  • Net Income Avi to Common (ttm)

    -836.13k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.73k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    146.01k

Research Analysis: BBBT

View More

Company Insights: BBBT

Research Reports: BBBT

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.